Who
Robert W. Postma
Director
Company insider
Files Form 4 as: Director, Alaunos Therapeutics.
In numbers
- Trades disclosed
- 27
- Buys
- 2
- Sells
- 0
- Bought
- $617K
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 4 Mar 2021
- Last trade
- 6 Oct 2026
- Last filed
- 8 Oct 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 6 Oct 2026filed 8 Oct 2026 | TCRT Alaunos TherapeuticsBiotechnology | SEC FORM 4 Code A | $16K21,829 at $0.7444 | filing |
| 23 Jul 2026filed 27 Jul 2026 | TCRT Alaunos TherapeuticsBiotechnology | SEC FORM 4 Code A | $16K8,463 at $1.92 | filing |
| 23 Jul 2026filed 27 Jul 2026 | TCRT Alaunos TherapeuticsBiotechnology | SEC FORM 4 Code A | $16K8,463 at $1.92 | filing |
| 29 Apr 2026filed 1 May 2026 | TCRT Alaunos TherapeuticsBiotechnology | SEC FORM 4 Code A | $16K6,274 at $2.59 | filing |
| 29 Apr 2026filed 1 May 2026 | TCRT Alaunos TherapeuticsBiotechnology | SEC FORM 4 Code A | $16K6,274 at $2.59 | filing |
| 12 Jan 2026filed 15 Jan 2026 | TCRT Alaunos TherapeuticsBiotechnology | SEC FORM 4 Code A | $16K5,622 at $2.89 | filing |
| 12 Jan 2026filed 15 Jan 2026 | TCRT Alaunos TherapeuticsBiotechnology | SEC FORM 4 Code A | $16K5,622 at $2.89 | filing |
| 21 Nov 2025filed 26 Nov 2025 | TCRT Alaunos TherapeuticsBiotechnology | SEC FORM 4 Code A | $16K5,142 at $3.16 | filing |
| 3 Jul 2025filed 7 Jul 2025 | TCRT Alaunos Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —6,400 at $0.00 | filing |
| 3 Jul 2025filed 7 Jul 2025 | TCRT Alaunos TherapeuticsBiotechnology | SEC FORM 4 Code A | —4,050 at $0.00 | filing |
| 24 Jun 2025filed 26 Jun 2025 | TCRT Alaunos Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code P | $2,694600 at $4.49 | filing |
| 13 Apr 2025filed 26 Jun 2025 | TCRT Alaunos TherapeuticsBiotechnology | SEC FORM 4 Code A | $61K20,804 at $2.92 | filing |
| 13 Apr 2025filed 15 Apr 2025 | TCRT Alaunos TherapeuticsBiotechnology | SEC FORM 4 Code A | $61K20,804 at $2.92 | filing |
| 11 Apr 2025filed 26 Jun 2025 | TCRT Alaunos Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code P | $1,380500 at $2.76 | filing |
| 11 Apr 2025filed 15 Apr 2025 | TCRT Alaunos Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code P | $1,380500 at $2.76 | filing |
| 6 Jun 2024filed 10 Jun 2024 | TCRT Alaunos Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —12,800 at $0.00 | filing |
| 6 Jun 2023filed 8 Jun 2023 | TCRT Alaunos Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —100,000 at $0.00 | filing |
| 29 Nov 2022filed 1 Dec 2022 | TCRT Alaunos TherapeuticsBiotechnology | SEC FORM 4 Bought | $488K750,000 at $0.65 | filing |
| 22 Jun 2022filed 24 Jun 2022 | TCRT Alaunos Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —100,000 at $0.00 | filing |
| 22 Jun 2022filed 24 Jun 2022 | TCRT Alaunos TherapeuticsBiotechnology | SEC FORM 4 Code A | —40,000 at $0.00 | filing |
News
Biotech Stock Alaunos Therapeutics (NASDAQ: TCRT) Sees Triple Digit Gains on Acquisition and FundingTCRT · investorideas.com · 13 Oct 2026Alaunos Therapeutics Announces Acquisition of Velaris TherapeuticsTCRT · manilatimes.net · 13 Oct 2026
0 headlines in the last 90 days name Robert W. Postma; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.